Knockdown of the JAG1 gene significantly reduced the potential for tumor organogenesis in triple-negative breast cancer (TNBC) cells, and JAG1-mediated adaptive resistance in Her2 breast cancer cells led to tumor recurrence (51). Here, JAG1 is linked to triple-negative breast carcinoma.